The Drug Regulatory Authority of Pakistan (DRAP) has launched an innovative e-service to modernise and streamline the registration process for pharmaceutical and biological products. This initiative encompasses various facets, such as local manufacturing, import, export, and licencing operations for manufacturers, aligning with DRAP’s strategy to ensure the highest standards of quality, safety, and efficacy in therapeutic goods within Pakistan. Applicants must adhere to the standardised data submission formats outlined in related documents. The newly introduced e-service allows applicants to submit their data electronically through the eAPP portal, resulting in faster and simpler data processing, a substantial reduction in paperwork, and the elimination of redundant processes. This digital platform enhances transparency and efficiency, marking a significant milestone in Pakistan’s regulatory framework for licencing and registration.
Where Industry Meet Trends
Menu
English